keyword
https://read.qxmd.com/read/38820071/metald-does-it-require-a-different-therapeutic-option
#1
JOURNAL ARTICLE
George W Marek, Harmeet Malhi
New guidelines for the definitions of steatotic liver disease have named the entity of MetALD as an overlap condition of metabolic-dysfunction associated steatotic liver disease (MASLD) and alcohol-related liver disease. There is a broad range of therapeutics in all stages of development for MASLD but these therapeutics in general have not been studied in patients with significant ongoing alcohol use. In this review we discuss the current understanding of the endogenous and exogenous risks for MASLD and MetALD...
May 31, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38818508/organokines-and-liver-enzymes-in-adolescent-girls-with-polycystic-ovary-syndrome-during-randomized-treatments
#2
RANDOMIZED CONTROLLED TRIAL
Cristina Garcia-Beltran, Marion Peyrou, Artur Navarro-Gascon, Abel López-Bermejo, Francis de Zegher, Francesc Villarroya, Lourdes Ibáñez
INTRODUCTION: Polycystic ovary syndrome (PCOS) is often associated with metabolic-associated fatty liver disease (MAFLD). MAFLD has been associated with altered hepatic function, systemic dysmetabolism, and abnormal circulating levels of signaling molecules called organokines. Here, we assessed the effects of two randomized treatments on a set of organokines in adolescent girls with PCOS and without obesity, and report the associations with circulating biomarkers of liver damage, which were assessed longitudinally in the aforementioned studies as safety markers...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38816541/transgenic-female-mice-producing-trans-10-cis-12-conjugated-linoleic-acid-present-excessive-prostaglandin-e2-adrenaline-corticosterone-glucagon-and-fgf21
#3
JOURNAL ARTICLE
Yu Rao, Lu-Wen Liang, Mei-Juan Li, Yang-Yang Wang, Bao-Zhu Wang, Ke-Mian Gou
Dietary trans 10, cis 12-conjugated linoleic acid (t10c12-CLA) is a potential candidate in anti-obesity trials. A transgenic mouse was previously successfully established to determine the anti-obesity properties of t10c12-CLA in male mice that could produce endogenous t10c12-CLA. To test whether there is a different impact of t10c12-CLA on lipid metabolism in both sexes, this study investigated the adiposity and metabolic profiles of female Pai mice that exhibited a dose-dependent expression of foreign Pai gene and a shift of t10c12-CLA content in tested tissues...
May 30, 2024: Scientific Reports
https://read.qxmd.com/read/38814610/analysis-of-the-efficacy-of-polyenyl-phosphatidylcholine-in-combination-with-liraglutide-in-nonalcoholic-fatty-liver-disease-and-the-effect-of-omentin-1-and-vaspin-expression
#4
JOURNAL ARTICLE
Yao Jin, Tong Liu, Zhiqiang Tong, Mei Dong
OBJECTIVE: To evaluate the efficacy of combining polyene phosphatidylcholine (PPC) with liraglutide in the treatment of nonalcoholic fatty liver disease (NAFLD) and investigate its impact on adipokine expression, specifically omentin-1 and vaspin. METHODS: One hundred twenty NAFLD patients were randomly assigned to either the observation group (n = 60) or the control group (n = 60). The control group received single-dose PPC treatment, while the observation group received a combination of PPC and liraglutide for 12 weeks...
May 24, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38806690/mutational-landscape-of-risk-variants-in-comorbid-depression-and-obesity-a-next-generation-sequencing-approach
#5
JOURNAL ARTICLE
Ana M Pérez-Gutiérrez, Rosario Carmona, Carlos Loucera, Jorge A Cervilla, Blanca Gutiérrez, Esther Molina, Daniel Lopez-Lopez, Javier Pérez-Florido, Juan Antonio Zarza-Rebollo, Elena López-Isac, Joaquín Dopazo, Luis Javier Martínez-González, Margarita Rivera
Major depression (MD) and obesity are complex genetic disorders that are frequently comorbid. However, the study of both diseases concurrently remains poorly addressed and therefore the underlying genetic mechanisms involved in this comorbidity remain largely unknown. Here we examine the contribution of common and rare variants to this comorbidity through a next-generation sequencing (NGS) approach. Specific genomic regions of interest in MD and obesity were sequenced in a group of 654 individuals from the PISMA-ep epidemiological study...
May 28, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38801850/fibroblast-growth-factor-21-enhances-learning-and-memory-performance-in-mice-by-regulating-hippocampal-l-lactate-homeostasis
#6
JOURNAL ARTICLE
Jiaojiao Xie, Jiapin Yan, Keru Ji, Yuejun Guo, Sibei Xu, Danjie Shen, Chen Li, Hongchang Gao, Liangcai Zhao
Fibroblast growth factor 21 (FGF21) is one endogenous metabolic molecule that functions as a regulator in glucose and lipid homeostasis. However, the effect of FGF21 on L-lactate homeostasis and its mechanism remains unclear until now. Forty-five Six-week-old male C57BL/6 mice were divided into three groups: control, L-lactate, and FGF21 (1.5 mg/kg) groups. At the end of the treatment, nuclear magnetic resonance-based metabolomics, and key proteins related to L-lactate homeostasis were determined respectively to evaluate the efficacy of FGF21 and its mechanisms...
May 25, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38801670/fgf21-mediating-sex-dependent-response-to-dietary-macronutrients
#7
JOURNAL ARTICLE
Karla A Soto Sauza, Karen K Ryan
Sex is key variable influencing body composition and substrate utilization. At rest, females maintain greater adiposity than males and resist the mobilization of fat. Males maintain greater lean muscle mass and mobilize fat readily. Determining the mechanisms that direct these sex-dependent effects is important for both reproductive and metabolic health. Here we highlight the fundamental importance of sex in shaping metabolic physiology and assess growing evidence that the hepatokine Fibroblast growth factor-21 (FGF21) plays a mechanistic role to facilitate sex-dependent responses to a changing nutritional environment...
May 27, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38798313/fgf21-acts-in-the-brain-to-drive-macronutrient-specific-changes-in-behavioral-motivation-and-brain-reward-signaling
#8
Md Shahjalal H Khan, Sora Q Kim, Robert C Ross, Florina Corpodean, Redin A Spann, Diana A Albarado, Sun O Fernandez-Kim, Blaise Clarke, Hans-Rudolf Berthoud, Heike Münzberg, David H McDougal, Yanlin He, Sangho Yu, Vance L Albaugh, Paul Soto, Christopher D Morrison
Dietary protein restriction induces adaptive changes in food preference, increasing protein consumption over carbohydrates or fat. We investigated whether motivation and reward signaling underpin these preferences. In an operant task, protein-restricted male mice increased their responding for liquid protein rewards, but not carbohydrate, fat, or sweet rewards. The protein restriction-induced increase in operant responding for protein was absent in Fgf21 -KO mice and mice with neuron-specific deletion of the FGF21 co-receptor beta-Klotho ( Klb Cam2ka ) mice...
May 13, 2024: bioRxiv
https://read.qxmd.com/read/38797835/a-secondary-analysis-of-indices-of-hepatic-and-beta-cell-function-following-12-weeks-of-carbohydrate-and-energy-restriction-vs-free-living-control-in-adults-with-type-2-diabetes
#9
JOURNAL ARTICLE
Cody Durrer, Hashim Islam, Haoning Howard Cen, Maria Dolores Moya Garzon, Xuchao Lyu, Sean McKelvey, Joel Singer, Alan M Batterham, Jonathan Z Long, James D Johnson, Jonathan P Little
BACKGROUND: Substantial weight loss in people living with type 2 diabetes (T2D) can reduce the need for glucose-lowering medications while concurrently lowering glycemia below the diagnostic threshold for the disease. Furthermore, weight-loss interventions have also been demonstrated to improve aspects of underlying T2D pathophysiology related to ectopic fat in the liver and pancreatic beta-cell function. As such, the purpose of this secondary analysis was to explore the extent to which a low-carbohydrate and energy-restricted (LCER) diet intervention improves markers of beta-cell stress/function, liver fat accumulation, and metabolic related liver function in people with type 2 diabetes...
May 27, 2024: Nutrition & Metabolism
https://read.qxmd.com/read/38797244/fgf21-as-a-mediator-of-adaptive-changes-in-food-intake-and-macronutrient-preference-in-response-to-protein-restriction
#10
REVIEW
Sora Q Kim, Redin A Spann, Md Shahjalal H Khan, Hans-Rudolf Berthoud, Heike Münzberg, Vance L Albaugh, Yanlin He, David McDougal, Paul Soto, Sangho Yu, Christopher D Morrison
Free-feeding animals navigate complex nutritional landscapes in which food availability, cost, and nutritional value can vary markedly. Animals have thus developed neural mechanisms that enable the detection of nutrient restriction, and these mechanisms engage adaptive physiological and behavioral responses that limit or reverse this nutrient restriction. This review focuses specifically on dietary protein as an essential and independently defended nutrient. Adequate protein intake is required for life, and ample evidence exists to support an active defense of protein that involves behavioral changes in food intake, food preference, and food motivation, likely mediated by neural changes that increase the reward value of protein foods...
May 24, 2024: Neuropharmacology
https://read.qxmd.com/read/38795981/the-endocrine-fgfs-axis-a-systemic-anti-fibrotic-response-that-could-prevent-pulmonary-fibrogenesis
#11
REVIEW
Mada Ghanem, Gabrielle Archer, Bruno Crestani, Arnaud A Mailleux
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease for which therapeutic options are limited, with an unmet need to identify new therapeutic targets. IPF is thought to be the consequence of repeated microlesions of the alveolar epithelium, leading to aberrant epithelial-mesenchymal communication and the accumulation of extracellular matrix proteins. The reactivation of developmental pathways, such as Fibroblast Growth Factors (FGFs), is a well-described mechanism during lung fibrogenesis...
May 23, 2024: Pharmacology & Therapeutics
https://read.qxmd.com/read/38790256/dna-microarray-and-bioinformatic-analysis-reveals-the-potential-of-whale-oil-in-enhancing-hair-growth-in-a-c57bl-6-mice-dorsal-skin-model
#12
JOURNAL ARTICLE
Junko Shibato, Fumiko Takenoya, Ai Kimura, Michio Yamashita, Satoshi Hirako, Randeep Rakwal, Seiji Shioda
Much research has been conducted to determine how hair regeneration is regulated, as this could provide therapeutic, cosmetic, and even psychological interventions for hair loss. The current study focused on the hair growth effect and effective utilization of fatty oil obtained from Bryde's whales through a high-throughput DNA microarray approach in conjunction with immunohistochemical observations. The research also examined the mechanisms and factors involved in hair growth. In an experiment using female C57BL/6J mice, the vehicle control group (VC: propylene glycol: ethanol: water), the positive control group (MXD: 3% minoxidil), and the experimental group (WO: 20% whale oil) were topically applied to the dorsal skin of the mouse...
May 15, 2024: Genes
https://read.qxmd.com/read/38789571/circulating-serum-fibroblast-growth-factor-21-as-risk-and-prognostic-biomarker-of-retinal-artery-occlusion
#13
JOURNAL ARTICLE
Ruobing Shi, Hang Liu, Kaichao Xia, Ying Li, Ting Chen, Xuejie Li, Anhuai Yang, Xuan Xiao
To evaluate the predictive and prognostic value of fibroblast growth factor 21 (FGF21) levels in retinal artery occlusion (RAO) patients. In this case-control study, serum FGF21 levels were detected by using the ELISA method. Multivariable logistic regression analyses were performed to evaluate the significance of FGF21 in assessing the risk of developing RAO and its impact on vision and concurrent ischemic stroke. Compared with control group, serum FGF21 levels were significantly higher (median [IQR] = 230...
May 24, 2024: Scientific Reports
https://read.qxmd.com/read/38788959/pregnane%C3%A2-x%C3%A2-receptor-pxr-deficiency-promotes-hepatocarcinogenesis-via-induction-of-akr1c18-expression-and-prostaglandin-f-2%C3%AE-pgf-2%C3%AE-levels
#14
JOURNAL ARTICLE
Tong Shi, Qiao-Ying Fan, Shi-Biao Liu, Shu-Yun Zhang
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Pregnane X receptor (PXR), a xenobiotic-sensing nuclear receptor, plays a critical role in the metabolism of endogenous and exogenous substances in the liver. Here, we investigate whether PXR plays a role in pathogenesis of HCC. We show that liver tumors were developed in diethylnitrosamine (DEN)-treated in PXR knockout (KO) mice. Hepatic levels of prostaglandin F2α (PGF2α ) and aldo-keto reductase family 1 member C18 (Akr1c18), a prostaglandin synthase of catalyzing reduction of PGH2 to PGF2α , were significantly elevated in DEN-treated PXR KO mice...
May 22, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38784036/causal-relationship-between-inflammatory-proteins-and-glioblastoma-a-two-sample-bi%C3%A2-directional-mendelian-randomization-study
#15
JOURNAL ARTICLE
Xiang Lin, Wei Gao, Chen Huang, Minghua Wu, Xiaoling She
Background: Observational studies have indicated a potential correlation between glioblastoma and circulating inflammatory proteins. Further investigation is required to establish a causal relationship between these two factors. Methods: We performed a Mendelian randomization (MR) analysis using genome-wide association study (GWAS) summary of 91 circulating inflammation-related proteins (N = 14,824) to assess their causal impact on glioblastoma. The GWAS summary data for glioblastoma included 243 cases and 287,137 controls...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38782182/obesity-and-masld-is-weight-loss-the-only-key-to-treat-metabolic-liver-disease
#16
REVIEW
Maximilian Huttasch, Michael Roden, Sabine Kahl
Metabolic dysfunction-associated steatotic liver disease (MASLD) closely associates with obesity and type 2 diabetes. Lifestyle intervention and bariatric surgery aiming at substantial weight loss are cornerstones of MASLD treatment by improving histological outcomes and reducing risks of comorbidities. Originally developed as antihyperglycemic drugs, incretin (co-)agonists and SGLT2 inhibitors also reduce steatosis and cardiorenovascular events. Certain incretin agonists effectively improve histological features of MASLD, but not fibrosis...
May 21, 2024: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/38782076/potential-of-fgf21-in-type-2-diabetes-mellitus-treatment-based-on-untargeted-metabolomics
#17
JOURNAL ARTICLE
Shuai Li, Zilong Song, Chunxiang Fan, Weiwei Zhang, Tianyi Ma, Xu Li, Qi Zhang, Ming Zhao, Tianfei Yu, Shanshan Li
Fibroblast growth factor 21 (FGF21) has promise for treating diabetes and its associated comorbidities. It has been found to reduce blood glucose in mice and humans; however, its underlying mechanism is not known. Here, the metabolic function of FGF21 in diabetes was investigated. Diabetic db/db mice received intraperitoneal injections of FGF21 for 28 days, the serum of each mouse was collected, and their metabolites were analyzed by untargeted metabolomics using UHPLC-MS/MS. It was found that FGF21 reduced blood glucose and oral glucose tolerance without causing hypoglycemia...
May 22, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38781402/cold-exposure-increases-circulating-fibroblast-growth-factor-21-in-the-evening-in-males-and-females
#18
JOURNAL ARTICLE
Carlijn Hoekx, Borja Martinez-Tellez, Maaike E Straat, Magdalena Verkleij, Mirjam Kemmeren, Sander Kooijman, Martin Uhrbom, Saskia C A de Jager, Patrick Rensen, Mariëtte Boon
OBJECTIVES: Cold exposure is linked to cardiometabolic benefits. Cold activates brown adipose tissue (BAT), increases energy expenditure, and induces secretion of the hormones fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15). The cold-induced increase in energy expenditure exhibits a diurnal rhythm in men. Therefore, we aimed to investigate the effect of cold exposure on serum FGF21 and GDF15 levels in humans and whether cold-induced changes in FGF21 and GDF15 levels differ between morning and evening in males and females...
May 1, 2024: Endocrine Connections
https://read.qxmd.com/read/38763495/a-novel-fatty-acid-mimetic-with-pan-ppar-partial-agonist-activity-inhibits-diet-induced-obesity-and-metabolic-dysfunction-associated-steatotic-liver-disease
#19
JOURNAL ARTICLE
Cigdem Sahin, Jenna-Rose Melanson, Florian Le Billan, Lilia Magomedova, Thais A M Ferreira, Andressa S Oliveira, Evan Pollock-Tahari, Michael F Saikali, Sarah B Cash, Minna Woo, Luiz A S Romeiro, Carolyn L Cummins
OBJECTIVE: The prevalence of metabolic diseases is increasing globally at an alarming rate; thus, it is essential that effective, accessible, low-cost therapeutics are developed. Peroxisome proliferator-activated receptors (PPARs) are transcription factors that tightly regulate glucose homeostasis and lipid metabolism and are important drug targets for the treatment of type 2 diabetes and dyslipidemia. We previously identified LDT409, a fatty acid-like compound derived from cashew nut shell liquid, as a novel pan-active PPARα/γ/δ compound...
May 17, 2024: Molecular Metabolism
https://read.qxmd.com/read/38750219/a-study-on-the-early-metabolic-effects-of-salt-and-fructose-consumption-the-protective-role-of-water
#20
JOURNAL ARTICLE
Nuri Baris Hasbal, Cicek Nur Bakir, Said Incir, Dimitrie Siriopol, Laura G Sanchez-Lozada, Miguel A Lanaspa, Richard J Johnson, Mehmet Kanbay
Increasing serum osmolality has recently been linked with acute stress responses, which over time can lead to increased risk for obesity, hypertension, and other chronic diseases. Salt and fructose are two major stimuli that can induce acute changes in serum osmolality. Here we investigate the early metabolic effects of sodium and fructose consumption and determine whether the effects of sodium or fructose loading can be mitigated by blocking the change in osmolality with hydration. Forty-four healthy subjects without disease and medication were recruited into four groups...
May 15, 2024: Hypertension Research: Official Journal of the Japanese Society of Hypertension
keyword
keyword
18766
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.